Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-02

Clinical Trial Update: Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update for Dutasteride (GI198745) in benign prostatic hyperplasia. Study completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2009-04-02